Adult Cardiac Surgery During Covid-19 Pandemic

Gerardo AK Laksono, Andreas MS Hutama, Paul L Tahalele

Abstract


Coronavirus Disease 2019 (COVID-19), which is caused by the SARS Coronavirus 2
(SARS-CoV-2), has affected over 200 countries worldwide. First case of COVID-19 was
found in Wuhan, China, precisely around December 2019. COVID-19, especially in those
with underlying health conditions or comorbidities, has an increasingly rapid and severe
progression, often leading to death. This virus is a single-strand RNA coronavirus, binding the angiotensin-converting enzyme 2 (ACE2) receptor which enters human cells. Coronavirus
disease has been reported to affect cardiac and vascular organs. cardiomyocyte death and
inflammation are results of a direct mechanism that involves viral infiltration into myocardial
tissue. Some cardiovascular manifestations of myocardial injuries associated with COVID-19
are arrhythmias, myocardial infarction, heart failure, and elevated biomarkers (cardiac
troponin I and brain-type natriuretic peptide). Some of this manifestation requires immediate intervention or surgery. Criteria are needed for hospitals or institutions that mostly maintain cardiac surgery services and surgery-urgent patients depending on severity of the disease and hospital resources. These criteria also limit the risk of exposure to patients and healthcare workers and allocate resources appropriately to those in greatest need. This paper aims to share our discussion and give an overview of patients undergoing cardiac surgery, providing clinicians with recommendations to triage and plan these procedures during the COVID-19 outbreak effectively.

Save to Mendeley


Keywords


Cardiovascular; adult cardiac surgery; covid-19

Full Text:

PDF

References


Aloysius MM, Thatti A, Gupta A, Sharma N, Bansal P, Goyal H. COVID-19 presenting as acute pancreatitis. Pancreatology. 2020;20(5):1026-1027. doi:10.1016/j.pan.2020.05.003

Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020;21:100331. doi:10.1016/j.eclinm.2020.100331

Covid19.go.id. Peta Sebaran.

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-292.e6. doi:10.1016/j.cell.2020.02.058

Landi A, Iannucci V, Van Nuffel A, Meuwissen P, Verhasselt B. One

Protein to Rule them All: Modulation of Cell Surface Receptors and Molecules by HIV Nef. Curr HIV Res. 2011;9(7):496504. doi:10.2174/157016211798842116

Fisman DN. Emerent infectious dis 2000. Emerg Infect Dis. 2000;6(6):601-608.

Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient with Coronavirus Disease 2019(COVID-19). JAMA Cardiol. 2020;2019:1-6. doi:10.1001/jamacardio.2020.1096

Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020:1930-1936. doi:10.1161/CIRCULATIONAHA.1 20.047164

Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):10691076. doi:10.1007/s42399-02000363-4

Su Y-B, Kuo M-J, Lin T-Y, et al. Cardiovascular manifestation and treatment in COVID-19. J Chinese Med Assoc. 2020;83(8):704-709. doi:10.1097/jcma.0000000000000352

Persatuan Ahli Bedah Indonesia. Surat Nomor 30/PP-PABI/III/2020 Pelayanan Bedah Pada Era Pandemi COVID-19 tanggal 21 Maret 2020. In: Jakarta: Persatuan Ahli Bedah Indonesia; 2020.

Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID19 patient needs an operation: operating room preparation and guidance. Can J nesth. 2020;67(6):756-758. doi:10.1007/s12630-020-01617-4

Haft JW, Atluri P, Ailawadi G, et al. Adult cardiac surgery during the COVID-19 pandemic: A tiered patient triage guidance statement. J Thorac Cardiovasc Surg. 2020;160(2):452-455. doi:10.1016/j.jtcvs.2020.04.011

Gunaydin S, Stammers AH. Perioperative management of COVID-19 patients undergoing cardiac surgery with cardiopulmonary bypass. Perfus (United Kingdom). 2020;35(6):465473. doi:10.1177/0267659120941341

Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 020:14431455. doi:10.1161/CIRCRESAHA.120.317055

Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID19). JAMA Cardiol. 2020;2019. doi:10.1001/jamacardio.2020.1017

Welt FGP, Shah PB, Aronow HD, et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the CC’s Interventional Council and SCAI. JAm Coll Cardiol. 2020;75(18):23722375. doi:10.1016/j.jacc.2020.03.021

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):247250. doi:10.1016/j.dsx.2020.03.013

Stadler K, Ha HR, Ciminale V, et al. Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. Am J .espir Cell Mol Biol. 2008;39(2):142-149. doi:10.1165/rcmb.2007-0217OC

Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585

Loungani RS, Rehorn MR, Newby LK, et al. A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response. Am Heart J. 2020;225:3-9. doi:10.1016/j.ahj.2020.04.024

Bakaeen FG, Gillinov AM, Roselli EE, et al. Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do. JThorac Cardiovasc Surg. 2020. doi:10.1016/j.jtcvs.2020.04.101

Hassan A, Arora RC, Lother SA, et al. Ramping Up the Delivery of Cardiac Surgery During the COVID-19 Pandemic: A Guidance Statement From the Canadian Society of Cardiac Surgeons. Can J Cardiol. 2020;36(7):1139-1143. doi:10.1016/j.cjca.2020.04.030

Chikwe J, Gaudino M, Hameed I, et al. Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: Guidance From an International Cardiac Surgery Consortium. Ann Thorac Surg. 2020;110(2):725-732. doi:10.1016/j.athoracsur.2020.05.004

George I, Salna M, Kobsa S, et al. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre. Eur J Cardio-Thoracic Surg. 2020;00:1-9. doi:10.1093/ejcts/ezaa228

Patel V, Jimenez E, Cornwell L, et al. Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations. J Am Heart Assoc. 2020;9(13):e017042. doi:10.1161/JAHA.120.017042

Laksono GA, Hutama AM, Tahalele PL. Thoracic Surgery Preparation, Patient Election, and Its Management During Covid-19 Pandemic: Surabaya Experiences. J Widya Med Jr. 2020;2(3):209-220. doi:10.33508/jwmj.v2i3.2666




DOI: https://doi.org/10.33508/jwmj.v2i4.2740

Refbacks

  • There are currently no refbacks.